Unfortunately, you won't see it. At this point, with acceptance of atryn and the manufacturing process in both Europe and the USA, no big pharma is interested int GTCB's process. To adopt it for them is to take a step back and throw away tons of money they have invested in their vat and cell culture research.
GTCB, sad to say, is a dead company walking and, imho, will not exist as it does today a year from now if not sooner.
As few where warning two years ago and were bullied and silenced by some on this board, Cox and management have been detrimental to the company and especially shareholders. The majority of the true believers are no longer holders of this stock.